Rx Times®

Rx Times® Pharmacy Magazine

[Rx Times® @rxtimes]

Bellicum Pharmaceuticals Announces Submission of BPX-701 and BPX-601 Clinical Trial Protocols for Review by the NIH https://t.co/UnWJJjMfrU

[Rx Times® @rxtimes]

McKesson Announces Fiscal 2016 Earnings Update and Preliminary Fiscal 2017 Outlook https://t.co/C7p5lWgS6n

[Rx Times® @rxtimes]

ExThera Medical Achieves Promising Preliminary Safety and Efficacy Results in a Large-Animal Model https://t.co/9JLaGshEOr

[Rx Times® @rxtimes]

Exelixis Submits Marketing Authorization Application in the European Union for Cabozantinib as a Treatment for https://t.co/p3gRI2lbMF

[Rx Times® @rxtimes]

Prescription Drug Prices Climbed 10.43 Percent in 2015, Further Squeezing Consumer Wallets as Lawmakers Step up https://t.co/3yBDPbJNaK

[Rx Times® @rxtimes]

Cidara Therapeutics Announces Positive Data from Multiple Dose Phase 1 Clinical Trial of CD101 IV https://t.co/inRVi1sOQw

[Rx Times® @rxtimes]

Presage Biosciences Appoints Oncology Experts to Newly Created Medical Advisory Panel https://t.co/5YJtwVpccl

[Rx Times® @rxtimes]

Broad-Based Patent Involving Innovative Extracorporeal Treatment Therapy Issued – Premier Biomedical Believes This C https://t.co/QDWQYUrA9s

[Rx Times® @rxtimes]

American Express Meeting & Events Partners with DoubleDutch to Launch Specialized Meetings App for Pharmaceutical https://t.co/qSLofY4dhX

[Rx Times® @rxtimes]

Aimmune Therapeutics Enrolls First Patient in Phase 3 PALISADE Trial of AR101 for the Treatment of Peanut Allergy https://t.co/DDTuerrb6F

[Rx Times® @rxtimes]

Iconic Therapeutics Closes Series C Financing With New and Existing Investors https://t.co/5NE62gzGsE

[Rx Times® @rxtimes]

Ironwood Pharmaceuticals Details Strategy to Build Top-Performing Commercial Biotechnology Company https://t.co/DI2jsDq4yI

[Rx Times® @rxtimes]

ACADIA Pharmaceuticals Appoints Jim Daly to Board of Directors https://t.co/pUxKmu1Mk5

[Rx Times® @rxtimes]

Trinity Partners Unveils 2016 Predictions for the Biopharmaceutical Industry https://t.co/3BYzW4cynj

[Rx Times® @rxtimes]

Research and Markets: Three Day Programme on Drafting Commercial Contracts for the Pharmaceutical Industry: 23-25 https://t.co/TWLGxM4YT1

[Rx Times® @rxtimes]

PCCA Compounding Pharmacist Nathaniel “Nat” Jones, R.Ph, FIACP Is Appointed to Texas Health and Human Services Pal https://t.co/mYEzlERGmq

[Rx Times® @rxtimes]

Angiocrine Bioscience Announces Collaboration for Clinical Cell Manufacturing Platform With Terumo BCT https://t.co/yTwVxc5NBk

[Rx Times® @rxtimes]

Research and Markets: Novel Applications of Drug Delivery Technologies Report – Snapshot of Innovations in R&D T https://t.co/LOARE9kVeD

[Rx Times® @rxtimes]

Halloran Consulting Group Expands Strategic Medical Expertise Capabilities with Addition of Chief Medical Officer https://t.co/NOMTzSVCN3

[Rx Times® @rxtimes]

Barton Health First to Implement Proteus Digital Health’s Innovative Solution for Patients with Chronic Conditions https://t.co/GgEzWUSthW